Clinical Trials / Research Studies
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Why are we doing this research?
The use of venetoclax-based therapies for pediatric patients with relapsed or refractory malignancies is increasingly common outside of the clinical trial setting. For patients who cannot swallow tablets, it is common to crush the tablets and dissolve them in liquid to create a solution. However, no PK data exists in adults or children using crushed tablets dissolved in liquid in this manner, and as a result, the venetoclax exposure with this solution is unknown.
Venetoclax PK: A Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution in Children and Young Adults With Hematologic Malignancies.
Who can participate?
Inclusion Criteria:
- Age: Patients must be <39 years of age at time of study enrollment
- Diagnosis: Patients may have a diagnosis of any hematologic malignancy
- Central access: Patients must have a central line for PK blood draws
- Weight requirement: Patients must weigh at least 5.5 kg at the time of enrollment
- Venetoclax: Patients must be receiving any dose of venetoclax given as a solution made from crushed tablets by mouth (PO) or via nasogastric (NG), or G-tube as prescribed by their treating oncologist.
- Concurrent chemotherapy medications: Patients may receive venetoclax as a single agent or in combination with any other chemotherapeutic agents.
Exclusion Criteria:
- Pregnant women are excluded from this study because venetoclax has the potential for teratogenic or abortifacient effects. Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with venetoclax, breastfeeding should be discontinued if the mother is treated with venetoclax.
- Males or females of reproductive potential may not participate unless they have agreed to use an effective contraceptive method while on study treatment and for six months following completion.
Ages
0 Years to 38 Years
Conditions
- Leukemia ALL New Diagnosis
- Adult - Leukemia ALL New Diagnosis
- Leukemia ALL Relapse - Refractory
- Adult - Leukemia ALL Relapse - Refractory
- Leukemia AML New Diagnosis
- Adult - Leukemia AML New Diagnosis
- Leukemia AML Relapse - Refractory
- Adult - Leukemia AML Relapse - Refractory
- Leukemia CML Relapse - Refractory
- Adult - Leukemia CML Relapse - Refractory
- Adult - Leukemia CML New Diagnosis
- Leukemia CML New Diagnosis
- Lymphoma Hodgkin New Diagnosis
- Adult - Lymphoma Hodgkin New Diagnosis
- Lymphoma Hodgkin Relapse - Refractory
- Adult - Lymphoma Hodgkin Relapse - Refractory
- Lymphoma Non-Hodgkin Relapse - Refractory
- Lymphoma Non-Hodgkin New Diagnosis
- Adult - Lymphoma Non-Hodgkin Relapse - Refractory
- Adult - Lymphoma Non-Hodgkin New Diagnosis
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
